WebApr 14, 2024 · Since HK-2-cells-generated-Abs, both by cisplatin or upon UV light exposure, can induce apoptosis in HK-2 cells, the purpose of this work was to study their metabolome and therein find the molecular features which help us to unravel the mechanisms of that phenomenon. WebSep 1, 2014 · Acute kidney injury (AKI), previously called acute renal failure (ARF) , is defined as an abrupt onset of renal dysfunction ranging from minor loss of function to failure [7,8,9]. AKI is a common clinical complication that develops in approximately 4%–7% of hospitalized patients each year and the prognosis can be poor [ 10 , 11 ].
Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease …
WebCisplatin for injection has been administered at 75 mg/m. 2 . to 100 mg/m. intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination regimens have been used. 2.4 Advanced Bladder Cancer . Cisplatin for injection has been administered at 50 mg/m. 2 . to 70 mg/m. intravenously per cycle once every 3 to 4 weeks. WebMar 23, 2024 · Here, we postulated that systemically delivered rapamycin perfluorocarbon nanoparticles (PFC NP) could reach the injured kidneys at sufficient and sustained concentrations to mitigate cisplatin-induced acute kidney injury … incidence of pancreatitis in india
Chapter 11. Chemotherapy and Kidney Injury
WebApr 12, 2024 · GFR allows a correct assessment of kidney function in patients with cancer undergoing cisplatin therapy. Abbreviations: BSA, body surface area; CKD-EPI, chronic kidney disease epidemiology collaboration; CRF, chronic renal failure; GFR, estimated-glomerular filtration rate; FPA, furanpropanoic acid; PAH, P-Amminoippurate; uCrCl, … WebMar 13, 2024 · Cisplatin (cis-diamminedichloroplatinum II, CDDP) is one of the most effective chemotherapeutic agents. However, its clinical use is limited due to the severe … WebNov 11, 2024 · Cisplatin (CDDP), a platinum drug, has been universally utilized to treat bladder cancer, ovarian cancer and other solid tumors ( Dasari and Tchounwou, 2014 ). However, the dominant factor restricting the clinical use of cisplatin is its nephrotoxicity ( Zhu et al., 2015 ). inboard fishing boats for sale